- Home
- RLX vs ITGR Comparison
RLX vs ITGR Comparison
Compare RLX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLX | ITGR |
|---|---|---|
| Founded | 2018 | 1970 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RLX | ITGR |
|---|---|---|
| Price | $2.23 | $87.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $2.50 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 2.2M | 723.5K |
| Earning Date | 03-13-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $48.73 | $1.69 |
| Revenue Next Year | $14.96 | $6.53 |
| P/E Ratio | ★ $28.09 | $30.01 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $1.66 | $62.00 |
| 52 Week High | $2.68 | $127.56 |
Technical Indicators
Market Signals| Indicator | RLX | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 55.64 |
| Support Level | $2.10 | $82.58 |
| Resistance Level | $2.42 | $88.36 |
| Average True Range (ATR) | 0.08 | 2.84 |
| MACD | -0.01 | 0.20 |
| Stochastic Oscillator | 43.28 | 60.55 |
Price Performance
Historical ComparisonAbout RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.